[
  {
    "ts": null,
    "headline": "Medical equipment maker Hologic lowers annual profit forecast on tariff uncertainty",
    "summary": "Medical equipment maker Hologic lowered its fiscal 2025 profit forecast, citing uncertainty around the tariffs imposed by U.S. President Donald Trump's administration, sending the company's shares down 3% after the bell on Thursday. The Marlborough, Massachusetts-based company makes test kits, diagnostic products and cancer screening devices. The company is lowering its adjusted profit outlook based on \"tariffs and geopolitical conditions\", said Chief Financial Officer Karleen Oberton.",
    "url": "https://finnhub.io/api/news?id=f2f2fff52be51f6fb647a515be621f18e5df43fc1eec0a06d5422fbe82016059",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746140297,
      "headline": "Medical equipment maker Hologic lowers annual profit forecast on tariff uncertainty",
      "id": 134185618,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "HOLX",
      "source": "Yahoo",
      "summary": "Medical equipment maker Hologic lowered its fiscal 2025 profit forecast, citing uncertainty around the tariffs imposed by U.S. President Donald Trump's administration, sending the company's shares down 3% after the bell on Thursday. The Marlborough, Massachusetts-based company makes test kits, diagnostic products and cancer screening devices. The company is lowering its adjusted profit outlook based on \"tariffs and geopolitical conditions\", said Chief Financial Officer Karleen Oberton.",
      "url": "https://finnhub.io/api/news?id=f2f2fff52be51f6fb647a515be621f18e5df43fc1eec0a06d5422fbe82016059"
    }
  },
  {
    "ts": null,
    "headline": "Hologic’s (NASDAQ:HOLX) Q1 Earnings Results: Revenue In Line With Expectations But Quarterly Revenue Guidance Significantly Misses Expectations",
    "summary": "Medical technology company Hologic (NASDAQ:HOLX) met Wall Street’s revenue expectations in Q1 CY2025, but sales fell by 1.2% year on year to $1.01 billion. On the other hand, next quarter’s revenue guidance of $1.01 billion was less impressive, coming in 2% below analysts’ estimates. Its non-GAAP profit of $1.03 per share was 1.4% above analysts’ consensus estimates.",
    "url": "https://finnhub.io/api/news?id=c95bd513fb408a24d515ae6dca59f69a6f799d52135a62422f055e182df898d8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746136246,
      "headline": "Hologic’s (NASDAQ:HOLX) Q1 Earnings Results: Revenue In Line With Expectations But Quarterly Revenue Guidance Significantly Misses Expectations",
      "id": 134185619,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "HOLX",
      "source": "Yahoo",
      "summary": "Medical technology company Hologic (NASDAQ:HOLX) met Wall Street’s revenue expectations in Q1 CY2025, but sales fell by 1.2% year on year to $1.01 billion. On the other hand, next quarter’s revenue guidance of $1.01 billion was less impressive, coming in 2% below analysts’ estimates. Its non-GAAP profit of $1.03 per share was 1.4% above analysts’ consensus estimates.",
      "url": "https://finnhub.io/api/news?id=c95bd513fb408a24d515ae6dca59f69a6f799d52135a62422f055e182df898d8"
    }
  },
  {
    "ts": null,
    "headline": "Hologic (HOLX) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates",
    "summary": "While the top- and bottom-line numbers for Hologic (HOLX) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.",
    "url": "https://finnhub.io/api/news?id=7b58df3852728f668750b224a476ca5c3e3080b5d2d820b77a39f4315ce79a11",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746135006,
      "headline": "Hologic (HOLX) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates",
      "id": 134185621,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "HOLX",
      "source": "Yahoo",
      "summary": "While the top- and bottom-line numbers for Hologic (HOLX) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.",
      "url": "https://finnhub.io/api/news?id=7b58df3852728f668750b224a476ca5c3e3080b5d2d820b77a39f4315ce79a11"
    }
  },
  {
    "ts": null,
    "headline": "Hologic (HOLX) Tops Q2 Earnings and Revenue Estimates",
    "summary": "Hologic (HOLX) delivered earnings and revenue surprises of 0.98% and 0.34%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?",
    "url": "https://finnhub.io/api/news?id=42a823bf1d993f4dd4dbf2861e1db921737e6a784cf1dd6625a312d433abadc1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746133806,
      "headline": "Hologic (HOLX) Tops Q2 Earnings and Revenue Estimates",
      "id": 134185511,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "HOLX",
      "source": "Yahoo",
      "summary": "Hologic (HOLX) delivered earnings and revenue surprises of 0.98% and 0.34%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?",
      "url": "https://finnhub.io/api/news?id=42a823bf1d993f4dd4dbf2861e1db921737e6a784cf1dd6625a312d433abadc1"
    }
  },
  {
    "ts": null,
    "headline": "Hologic, Inc. (HOLX) Q2 2025 Earnings Call Transcript",
    "summary": "Hologic, Inc. (NASDAQ:HOLX) Q2 2025 Earnings Conference Call May 1, 2025 4:30 PM ETCompany ParticipantsMike Watts - Corporate VP, IRSteve MacMillan -...",
    "url": "https://finnhub.io/api/news?id=9637a3c97286b84b89b467c8dc0127a568d93e3145669f532005e5e6abbfcd96",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746131087,
      "headline": "Hologic, Inc. (HOLX) Q2 2025 Earnings Call Transcript",
      "id": 134178444,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "HOLX",
      "source": "SeekingAlpha",
      "summary": "Hologic, Inc. (NASDAQ:HOLX) Q2 2025 Earnings Conference Call May 1, 2025 4:30 PM ETCompany ParticipantsMike Watts - Corporate VP, IRSteve MacMillan -...",
      "url": "https://finnhub.io/api/news?id=9637a3c97286b84b89b467c8dc0127a568d93e3145669f532005e5e6abbfcd96"
    }
  },
  {
    "ts": null,
    "headline": "Hologic: Fiscal Q2 Earnings Snapshot",
    "summary": "The Marlborough, Massachusetts-based company said it had a loss of 8 cents per share. Earnings, adjusted for one-time gains and costs, were $1.03 per share. The results topped Wall Street expectations.",
    "url": "https://finnhub.io/api/news?id=d5fb135ab95c73eeb501dcf4472c3f8e09dc26f6dbfeb43b92c749e0edb03a6e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746130627,
      "headline": "Hologic: Fiscal Q2 Earnings Snapshot",
      "id": 134185623,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "HOLX",
      "source": "Yahoo",
      "summary": "The Marlborough, Massachusetts-based company said it had a loss of 8 cents per share. Earnings, adjusted for one-time gains and costs, were $1.03 per share. The results topped Wall Street expectations.",
      "url": "https://finnhub.io/api/news?id=d5fb135ab95c73eeb501dcf4472c3f8e09dc26f6dbfeb43b92c749e0edb03a6e"
    }
  },
  {
    "ts": null,
    "headline": "Hologic Announces Financial Results for Second Quarter of Fiscal 2025",
    "summary": "MARLBOROUGH, Mass., May 01, 2025--Hologic Announces Financial Results for Second Quarter of Fiscal 2025",
    "url": "https://finnhub.io/api/news?id=17774e4377b51c8329b8327049ab8c35ae432044a8bb301ba4c97dba1f8c5acb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746129660,
      "headline": "Hologic Announces Financial Results for Second Quarter of Fiscal 2025",
      "id": 134185624,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "HOLX",
      "source": "Yahoo",
      "summary": "MARLBOROUGH, Mass., May 01, 2025--Hologic Announces Financial Results for Second Quarter of Fiscal 2025",
      "url": "https://finnhub.io/api/news?id=17774e4377b51c8329b8327049ab8c35ae432044a8bb301ba4c97dba1f8c5acb"
    }
  },
  {
    "ts": null,
    "headline": "Hologic Inc. stock underperforms Thursday when compared to competitors",
    "summary": "Hologic Inc. stock underperforms Thursday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=dab1c7de5a757f43583e4ea8a76b3777b1f339d25bb7a8f3e7057555aa2ae4d9",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746119700,
      "headline": "Hologic Inc. stock underperforms Thursday when compared to competitors",
      "id": 134286828,
      "image": "",
      "related": "HOLX",
      "source": "MarketWatch",
      "summary": "Hologic Inc. stock underperforms Thursday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=dab1c7de5a757f43583e4ea8a76b3777b1f339d25bb7a8f3e7057555aa2ae4d9"
    }
  }
]